Review
Open access
Oct 2026
Diabesity: an old term, a modern challenge — multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes
Evidence for approved and investigational oral incretin therapies, dual and triple receptor agonists, amylin-based strategies, established antidiabetic drugs, and adjunctive approaches targeting body composition are summarized.
Karolina Hoffmann, Weronika Pucek, Wiktoria Skrzypek et al.
· Journal of Pharmacy & Ph... · 0 citations